Updated: Jun 23

LIQID Medical was just awarded another Design Innovation Seed Fund from the Technology and Innovation Agency. This funding is earmarked for the development of the iFlow device and implementation of an ISO13485 Quality Management System.


Updated: Jan 8

After our incredible SAB Foundation grant win, LIQID Medical has begun live trials. Two patients underwent OptiShunt insertion on the 9th December 2019. So far the results are promising and we look forward to improving the speed and technique with which the surgery is carried out. 2020 is off to a great start and we are excited to track the long term outcomes as we progress.


Klara Strydom joins our team as Clinical Trial Co-ordinator. Klara has vast research experience including protocol development, manuscript development and publication, trial management, data collection and analysis, building data capturing databases and MOOC conceptualisation, planning and execution. Currently she is pursuing her PhD at the Division of Human Nutrition, Stellenbosch University.


Glaucoma remains a leading cause of blindness worldwide, affecting over 70 million people

Contact

Dr Daemon McClunan, Founder
email: daemon@liqidmedical.com

mobile: +27 (0)84 604 7600

location: Cape Town, South Africa

You Tube icon white edited

© 2017 Copyright reserved. Online Solutions by CassandraGroenewald.com